Unknown

Dataset Information

0

Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection.


ABSTRACT: Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)-2 infection induces an exacerbated inflammation driven by innate immunity components. Dendritic cells (DCs) play a key role in the defense against viral infections, for instance plasmacytoid DCs (pDCs), have the capacity to produce vast amounts of interferon-alpha (IFN-α). In COVID-19 there is a deficit in DC numbers and IFN-α production, which has been associated with disease severity. In this work, we described that in addition to the DC deficiency, several DC activation and homing markers were altered in acute COVID-19 patients, which were associated with multiple inflammatory markers. Remarkably, previously hospitalized and nonhospitalized patients remained with decreased numbers of CD1c+ myeloid DCs and pDCs seven months after SARS-CoV-2 infection. Moreover, the expression of DC markers such as CD86 and CD4 were only restored in previously nonhospitalized patients, while no restoration of integrin β7 and indoleamine 2,3-dyoxigenase (IDO) levels were observed. These findings contribute to a better understanding of the immunological sequelae of COVID-19.

SUBMITTER: Perez-Gomez A 

PROVIDER: S-EPMC8294321 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-SCDT-EMBOJ-2021-109622 | biostudies-other
| S-EPMC8028697 | biostudies-literature
| S-EPMC7402670 | biostudies-literature
| S-EPMC9686051 | biostudies-literature
| S-EPMC9505545 | biostudies-literature
2020-07-25 | GSE155106 | GEO
| S-SCDT-10_1038-S44318-024-00061-0 | biostudies-other
| S-EPMC11337933 | biostudies-literature
| S-EPMC8079668 | biostudies-literature
| S-EPMC8555109 | biostudies-literature